Beta Drugs IPO Latest News Today

Track all the latest updates and news of Beta Drugs IPO.

1. Alumis readies $300 million IPO ahead of Phase 3 trial for plaque psoriasis drug

   June 24, 2024 7:10:00 PM

   Alumis Inc. on Monday said it plans to offer 17.65 million shares at an estimated price range of $16 to $18 a share in its upcoming initial public offering. At the midpoint of its range, Alumis will ...

   Published by : MarketWatch on MSN

2. Alumis grosses $250 million with IPO and private placement

   June 28, 2024 6:32:00 PM

   In all, the IPO and private placement are expected to gross $250 million, Alumis said. Alumis also granted to the IPO's underwriters a 30-day option to buy up to an additional 1,968,750 shares at the ...

   Published by : The Business Journals

3. U.S. IPO Weekly Recap: 2Q IPO Market Closes Out With Sizable Pricings And Pipeline Additions

   July 1, 2024 7:21:00 PM

   The IPO market closed out June with four deals, three of which raised $100+ million. In the pipeline, nine companies submitted initial filings, led by what could be the largest IPO of 2024 to date.

   Published by : Seeking Alpha

4. Biopharma Firm Alumis Shares Sink 17% After Downsized IPO

   June 28, 2024 8:31:00 PM

   Shares of Alumis Inc. sank 20% in the clinical stage biopharmaceutical company�s public debut, after it raised $250 million in a downsized initial public offering with a concurrent private placement.

   Published by : Bloomberg L.P.

5. IPO roundup: SLRA, OS, and more

   July 1, 2024 8:14:00 PM

   The IPO market is off to a slow start in July, though some small issuers may join the calendar throughout the week. Last week wrapped up with a mixed bag of performers, web comic platform WEBTOON ...

   Published by : Seeking Alpha on MSN

6. Drug-Trial Software Maker Clario Files Confidentially for IPO

   June 25, 2024 6:26:00 PM

   To move ahead with its listing, Clario will have to file a public version of the draft IPO registration submitted confidentially to the US Securities and Exchange Commission.

   Published by : Yahoo Finance

7. Third Rocks Rapport reveals upsized $154M IPO

   June 7, 2024 2:30:00 PM

   Just a few days after Rapport Therapeutics revealed plans for a $122 million IPO, the epilepsy biotech has unveiled an upsized $154 million offering. The Third Rock company�s IPO consists of 8 ...

   Published by : FierceBiotech

8. Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials

   June 10, 2024 12:04:00 PM

   Not content with bringing in one of the largest private biotech fundraises of 2024 so far, Alumis has now become the latest drug developer ... to use part of the IPO haul to advance the ...

   Published by : FierceBiotech

9. Shein IPO Should Be A No Brainer Investment, Yet Caution Reigns

   June 12, 2024 5:15:00 PM

   The founder of Gen Z super brand Shein must be wondering whether the company will ever catch a break over the long-running soap opera that is the fashion retailer�s much vaunted IPO. On the face ...

   Published by : Forbes

10. Alumis readies IPO to fund rival drug to Bristol Myers� Sotyktu

    June 10, 2024 6:30:00 AM

    Alumis also has a similar central nervous system-targeting drug in a Phase 1 trial, according to its IPO filing. After a fast start this year, the pace of biotech IPOs has slowed, with 11 ...

    Published by : Yahoo Finance

11. Tencent-Backed AI Drug Discovery Startup Xtalpi Rises In Hong Kong Debut

    June 13, 2024 4:29:00 PM

    Left to right: Xtalpi cofounders Ma Jian, Wen Shuhao and Lai Lipeng attend the company�s IPO ceremony in Hong Kong on June 13, 2024. Shares of Xtalpi, a Shenzhen-based AI drug discovery startup ...

    Published by : Forbes

Beta Drugs IPO Alerts